Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel mass drug administration with versus without prior diagnosis for intestinal schistosomiasis compliance
PACTR201804003343404Recruiting
- Sponsor
- Catholic University of Health and Allied Sciences
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of praziquantel in intestinal schistosomiasis (2 arms), sponsored by Catholic University of Health and Allied Sciences. Primary endpoints: Treatment coverage and Geographical cluster coverage. Started Aug 2017; status: recruiting.
02
Drugs
praziquantel
03
Conditions
intestinal schistosomiasis
Beyond the preview
Go deeper on PACTR201804003343404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201804003343404.